Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Int.biotech. (IBT) Share Price

Price 1,120.00p on 14-07-2026 at 11:28:14
Change -20.00p -1.75%
Buy 1,130.00p
Sell 1,120.00p
Last Trade: Buy 133.00 at 1,127.4589p
Day's Volume: 84,315
Last Close: 1,140.00p
Open: 1,130.00p
ISIN: GB0004559349
Day's Range 1,115.00p - 1,140.00p
52wk Range: 626.00p - 1,215.00p
Market Capitalisation: £356.19m
VWAP: 1,121.59142p
Shares in Issue: 31.80m

Int.biotech. (IBT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 133 1,127.4589p Ordinary
12:28:13 - 14-Jul-26
Buy* 14 1,127.444p Suspected BUY Trade
12:13:58 - 14-Jul-26
Sell* 1,358 1,124.01p Ordinary
12:13:40 - 14-Jul-26
Sell* 354 1,124.00p Ordinary
11:46:33 - 14-Jul-26
Buy* 1 1,128.891p Suspected BUY Trade
11:43:59 - 14-Jul-26
Buy* 1,000 1,125.99p Ordinary
11:29:39 - 14-Jul-26
Buy* 37 1,120.00p Suspected BUY Trade
11:23:56 - 14-Jul-26
Buy* 8 1,120.00p SI Trade
11:17:59 - 14-Jul-26
Buy* 4,449 1,118.00p Ordinary
11:15:37 - 14-Jul-26
Buy* 63 1,120.00p Automatic Execution
11:07:25 - 14-Jul-26
See more Int.biotech. trades

Int.biotech. (IBT) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Jul 2026 (Mon) 1,130.00 1,165.00 1,130.00 1,140.00 112,629
10th Jul 2026 (Fri) 1,185.00 1,185.00 1,130.00 1,130.00 194,271
9th Jul 2026 (Thu) 1,215.00 1,215.00 1,190.00 1,190.00 59,229
8th Jul 2026 (Wed) 1,165.00 1,210.00 1,165.00 1,205.00 166,973
7th Jul 2026 (Tue) 1,115.00 1,160.00 1,115.00 1,155.00 137,786
6th Jul 2026 (Mon) 1,105.00 1,115.00 1,100.00 1,110.00 68,320
3rd Jul 2026 (Fri) 1,105.00 1,105.00 1,080.00 1,095.00 34,806
2nd Jul 2026 (Thu) 1,070.00 1,090.00 1,070.00 1,075.00 189,548
1st Jul 2026 (Wed) 1,095.00 1,095.00 1,070.00 1,085.00 79,225
30th Jun 2026 (Tue) 1,080.00 1,095.00 1,075.00 1,095.00 61,427
29th Jun 2026 (Mon) 1,060.00 1,075.00 1,060.00 1,070.00 126,871
26th Jun 2026 (Fri) 1,055.00 1,060.00 1,055.00 1,060.00 64,384
25th Jun 2026 (Thu) 1,045.00 1,060.00 1,040.00 1,060.00 59,444
24th Jun 2026 (Wed) 1,040.00 1,050.00 1,030.00 1,050.00 50,886
23rd Jun 2026 (Tue) 998.00 1,035.00 998.00 1,030.00 43,674
22nd Jun 2026 (Mon) 1,000.00 1,015.00 988.00 1,015.00 53,190
19th Jun 2026 (Fri) 998.00 1,000.00 996.00 1,000.00 92,222
18th Jun 2026 (Thu) 986.00 998.00 986.00 992.00 62,302
17th Jun 2026 (Wed) 968.00 990.00 966.00 990.00 35,549
16th Jun 2026 (Tue) 960.00 968.00 954.00 966.00 25,689
15th Jun 2026 (Mon) 964.00 974.00 960.00 974.00 71,007
See more Int.biotech. price history

Int.biotech. (IBT) Regulatory News

Date Source Headline
13th Jul 2026 11:33 am RNS Net Asset Value(s)
10th Jul 2026 10:59 am RNS Net Asset Value(s)
9th Jul 2026 11:27 am RNS Net Asset Value(s)
8th Jul 2026 5:26 pm RNS Transaction in Own Shares
8th Jul 2026 11:39 am RNS Net Asset Value(s)
7th Jul 2026 11:34 am RNS-R Portfolio company Crinetics acquired by Vertex
7th Jul 2026 11:23 am RNS Net Asset Value(s)
6th Jul 2026 11:22 am RNS Net Asset Value(s)
6th Jul 2026 7:00 am RNS Dividend Declaration
3rd Jul 2026 5:30 pm RNS Block Listing Interim Review
See more Int.biotech. regulatory news

Int.biotech. (IBT) Share News

IBT company Crinetics to be acquired by Vertex for USD10 billion

7th Jul 2026 19:11

(Alliance News) - International Biotechnology Trust PLC on Tuesday said its portfolio company, Crinetics Pharmaceuticals Inc, entered a deal to be acquired by Vertex Pharmaceuticals Inc in a deal worth USD10 billion. Read More

IN BRIEF: International Biotech highlights deal for investee Apogee

22nd Jun 2026 20:07

International Biotechnology Trust PLC - invests in biotechnology companies - Notes announcement that investee company Apogee Therapeutics is to be acquired by AbbVie Inc. Apogee shareholders will receive USD135.11 per share in cash at closing. As at close of business on Friday, Apogee represented around 0.41% of IBT's net asset value. IBT Portfolio Managers Ailsa Craig and Marek Poszepczynski say: "The biotech M&A boom shows no signs of slowing, with deal flow running ahead of last year's pace. The latest deal represents the seventh acquisition within the IBT portfolio in 2026 so far, compared to three acquisitions at the same stage last year, with the total value of the companies acquired also up 9%. This demonstrates the success of our investment strategy." Read More

EARNINGS: Griffin Mining revenue jumps; Andrews Sykes holds payout

12th May 2026 12:48

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

International Biotechnology Trust expects more M&A after Soleno deal

7th Apr 2026 11:27

(Alliance News) - International Biotechnology Trust PLC on Tuesday said another portfolio company has agreed to be taken over, the fourth such deal in a matter of weeks. Read More

Apellis investors respond to USD5.60 billion Biogen acquisition

1st Apr 2026 16:17

(Alliance News) - Biotech Growth Trust PLC, International Biotechnology Trust PLC, ad RTW Biotech Opportunities Ltd have all noted the agreement announced by Biogen Inc on Tuesday to acquire Apellis Pharmaceuticals, Inc. Read More

See more Int.biotech. news
FTSE 100 Latest
Value10,473.70
Change-24.59

Login to your account

Forgot Password?

Not Registered